Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This creates a frustrating cycle where treating diabetes worsens one of its underlying causes
Please note that this article is not meant to be medical advice
Meanwhile, Sanofi has continued the trend of creating separate consumer healthcare and pharma businesses, transferring its consumer operations into a new company, Opella, and selling half of it to a US investment firm
Hypoglycemia, dangerously low blood sugar, is a concern primarily for people taking semaglutide alongside other diabetes medications like insulin or sulfonylureas
Individuals who develop blood clots are often at risk for developing more despite intervention to remove or resolve the clots
Both drugs can cause mild-to-moderate gastrointestinal issues, though these tend to be manageable and go away as your body adjusts to the medication
